Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Clinical trial NCT02768363 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02768363
- Sponsor
- Candel Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2024-11-01
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.